Latest & greatest articles for amoxicillin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on amoxicillin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on amoxicillin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for amoxicillin

21. Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive

Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Full-mouth scaling and root planing (FMSRP) in combination with amoxicillin (AMX)/metronidazole (MET) (FMSRP + AMX/MET) therapy is more effective in treating generalized aggressive periodontitis (GAgP) than is FMSRP alone. Critical Summary Assessment

2013 ADA Center for Evidence-Based Dentistry

22. Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive

Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Full-mouth scaling and root planing (FMSRP) in combination with amoxicillin (AMX)/metronidazole (MET) (FMSRP + AMX/MET) therapy is more effective in treating generalized aggressive periodontitis (GAgP) than is FMSRP alone. Critical Summary Assessment

2013 ADA Center for Evidence-Based Dentistry

23. Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic

Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Preliminary evidence suggests scaling and root planing (SRP) in combination with amoxicillin (AMX)/metronidazole (MET) (SRP + AMX/MET) therapy may be more effective in treating chronic periodontitis (CP) than is SRP alone. Critical Summary Assessment

2013 ADA Center for Evidence-Based Dentistry

24. Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic

Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Preliminary evidence suggests scaling and root planing (SRP) in combination with amoxicillin (AMX)/metronidazole (MET) (SRP + AMX/MET) therapy may be more effective in treating chronic periodontitis (CP) than is SRP alone. Critical Summary Assessment

2013 ADA Center for Evidence-Based Dentistry

25. Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive

Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Full-mouth scaling and root planing (FMSRP) in combination with amoxicillin (AMX)/metronidazole (MET) (FMSRP + AMX/MET) therapy is more effective in treating generalized aggressive periodontitis (GAgP) than is FMSRP alone. Critical Summary Assessment

2013 ADA Center for Evidence-Based Dentistry

26. ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD. (PubMed)

ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD. 23552686 2013 05 13 2013 04 04 1539-3704 158 6 2013 Mar 19 Annals of internal medicine Ann. Intern. Med. ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD. JC3 10.7326/0003-4819-158-6-201303190-02003 Adams Sandra G SG University of Texas Health Science Center at San Antonio and South Texas Veterans

2013 Annals of Internal Medicine

27. Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy--EORTC Infectiou (PubMed)

Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy--EORTC Infectiou This double-blind, multicenter trial compared the efficacy and safety of a single daily oral dose of moxifloxacin with oral combination therapy in low-risk febrile neutropenic patients with cancer.Inclusion criteria were cancer, febrile (...) neutropenia, low risk of complications as predicted by a Multinational Association for Supportive Care in Cancer (MASCC) score > 20, ability to swallow, and ≤ one single intravenous dose of empiric antibiotic therapy before study drug treatment initiation. Early discharge was encouraged when a set of predefined criteria was met. Patients received either moxifloxacin (400 mg once daily) monotherapy or oral ciprofloxacin (750 mg twice daily) plus amoxicillin/clavulanic acid (1,000 mg twice daily). The trial

2013 EvidenceUpdates

28. Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures

Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Systematic antimicrobial therapy using a combination of amoxicillin and metronidazole as an adjunct to scaling and root planing (SRP) can enhance the clinical benefits of non-surgical periodontal therapy in otherwise healthy teens and adults. Critical Summary

2013 ADA Center for Evidence-Based Dentistry

29. Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures

Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Systematic antimicrobial therapy using a combination of amoxicillin and metronidazole as an adjunct to scaling and root planing (SRP) can enhance the clinical benefits of non-surgical periodontal therapy in otherwise healthy teens and adults. Critical Summary

2013 ADA Center for Evidence-Based Dentistry

30. Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures

Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Systematic antimicrobial therapy using a combination of amoxicillin and metronidazole as an adjunct to scaling and root planing (SRP) can enhance the clinical benefits of non-surgical periodontal therapy in otherwise healthy teens and adults. Critical Summary

2013 ADA Center for Evidence-Based Dentistry

31. Randomised controlled trial: A 10-day course of amoxicillin does not reduce symptoms of acute rhinosinusitis at day 3 of treatment

Randomised controlled trial: A 10-day course of amoxicillin does not reduce symptoms of acute rhinosinusitis at day 3 of treatment A 10-day course of amoxicillin does not reduce symptoms of acute rhinosinusitis at day 3 of treatment | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A 10-day course of amoxicillin does not reduce symptoms of acute rhinosinusitis at day 3 of treatment Article Text Therapeutics Randomised controlled

2013 Evidence-Based Medicine (Requires free registration)

32. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial. (PubMed)

Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial. Pneumonia is a leading global cause of morbidity and mortality in children younger than 5 years. In Pakistan, the proportion of deaths due to pneumonia is higher in rural areas than it is in urban areas, with a substantial proportion of individuals dying at home because referral for care is problematic (...) screened by LHWs and those diagnosed with severe pneumonia were prescribed oral amoxicillin syrup (90 mg/kg per day in two doses) for 5 days at home. Children in control clusters were given one dose of oral co-trimoxazole and were referred to their nearest health facility for admission and intravenous antibiotics, as per government policy. In both groups, follow-up visits at home were done at days 2, 3, 6, and 14 by LHW. The primary outcome was treatment failure by day 6 after enrolment. We matched

2012 Lancet

33. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. (Full text)

Amoxicillin for acute rhinosinusitis: a randomized controlled trial. Evidence to support antibiotic treatment for acute rhinosinusitis is limited, yet antibiotics are commonly used.To determine the incremental effect of amoxicillin treatment over symptomatic treatments for adults with clinically diagnosed acute rhinosinusitis.A randomized, placebo-controlled trial of adults with uncomplicated, acute rhinosinusitis were recruited from 10 community practices in Missouri between November 1, 2006 (...) , and May 1, 2009.Ten-day course of either amoxicillin (1500 mg/d) or placebo administered in 3 doses per day. All patients received a 5- to 7-day supply of symptomatic treatments for pain, fever, cough, and nasal congestion to use as needed.The primary outcome was improvement in disease-specific quality of life after 3 to 4 days of treatment assessed with the Sinonasal Outcome Test-16 (minimally important difference of 0.5 units on a 0-3 scale). Secondary outcomes included the patient's retrospective

2012 JAMA PubMed

34. Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. (PubMed)

Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. Researchers have suggested that antibiotics could cure acute appendicitis. We assessed the efficacy of amoxicillin plus clavulanic acid by comparison with emergency appendicectomy for treatment of patients with uncomplicated acute appendicitis.In this open-label, non-inferiority, randomised trial, adult patients (aged 18-68 years (...) ) with uncomplicated acute appendicitis, as assessed by CT scan, were enrolled at six university hospitals in France. A computer-generated randomisation sequence was used to allocate patients randomly in a 1:1 ratio to receive amoxicillin plus clavulanic acid (3 g per day) for 8-15 days or emergency appendicectomy. The primary endpoint was occurrence of postintervention peritonitis within 30 days of treatment initiation. Non-inferiority was shown if the upper limit of the two-sided 95% CI for the difference

2011 Lancet

35. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial. (Full text)

Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial. First dose oral co-trimoxazole and referral are recommended for WHO-defined severe pneumonia. Difficulties with referral compliance are reported in many low-resource settings, resulting in low access to appropriate treatment. The objective in this study was to assess whether community case management by lady health workers (LHWs) with oral (...) amoxicillin in children with severe pneumonia was equivalent to current standard of care.In Haripur district, Pakistan, 28 clusters were randomly assigned with stratification in a 1:1 ratio to intervention and control clusters by use of a computer-generated randomisation sequence. Children were included in the study if they were aged 2-59 months with WHO-defined severe pneumonia and living in the study area. In the intervention clusters, community-based LHWs provided mothers with oral amoxicillin (80-90

2011 Lancet PubMed

36. Randomised controlled trial: Training birth attendants in rural Zambia in neonatal resuscitation, and the use of amoxicillin coupled with facilitated referral, reduces neonatal mortality

Randomised controlled trial: Training birth attendants in rural Zambia in neonatal resuscitation, and the use of amoxicillin coupled with facilitated referral, reduces neonatal mortality Training birth attendants in rural Zambia in neonatal resuscitation, and the use of amoxicillin coupled with facilitated referral, reduces neonatal mortality | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings (...) in neonatal resuscitation, and the use of amoxicillin coupled with facilitated referral, reduces neonatal mortality Article Text Therapeutics Randomised controlled trial Training birth attendants in rural Zambia in neonatal resuscitation, and the use of amoxicillin coupled with facilitated referral, reduces neonatal mortality David R Marsh 1 , Stephen N Wall 2 Statistics from Altmetric.com Commentary on: Gill CJ , Phiri-Mazala G , Guerina NG , et al . Effect of training traditional birth attendants

2011 Evidence-Based Medicine (Requires free registration)

37. Randomised controlled trial: Amoxicillin-clavulanate improves symptoms, reduces treatment failure in select children with acute otitis media and increases risk of diarrhoea

Randomised controlled trial: Amoxicillin-clavulanate improves symptoms, reduces treatment failure in select children with acute otitis media and increases risk of diarrhoea Amoxicillin-clavulanate improves symptoms, reduces treatment failure in select children with acute otitis media and increases risk of diarrhoea | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time (...) . To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Amoxicillin-clavulanate improves symptoms, reduces treatment failure in select

2011 Evidence-Based Medicine (Requires free registration)

38. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children (PubMed)

Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children The role of antibiotic therapy in managing acute bacterial sinusitis (ABS) in children is controversial. The purpose of this study was to determine the effectiveness of high-dose amoxicillin/potassium clavulanate in the treatment of children diagnosed with ABS.This was a randomized, double-blind, placebo-controlled study. Children 1 to 10 years of age with a clinical presentation (...) compatible with ABS were eligible for participation. Patients were stratified according to age (<6 or >or=6 years) and clinical severity and randomly assigned to receive either amoxicillin (90 mg/kg) with potassium clavulanate (6.4 mg/kg) or placebo. A symptom survey was performed on days 0, 1, 2, 3, 5, 7, 10, 20, and 30. Patients were examined on day 14. Children's conditions were rated as cured, improved, or failed according to scoring rules.Two thousand one hundred thirty-five children

2009 EvidenceUpdates

39. Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial (Full text)

Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial Antibiotic treatment is not recommended for acute bronchitis in immunocompetent patients in industrialised countries. Whether these recommendations are relevant to the developing world and to immunocompromised patients is unknown.Randomised, triple blind, placebo controlled equivalence trial of amoxicillin compared with placebo in 660 adults presenting (...) to two outpatient clinics in Nairobi, Kenya, with acute bronchitis but without evidence of chronic lung disease.The primary study end point was clinical cure, as defined by a >or=75% reduction in a validated Acute Bronchitis Severity Score by 14 days; analysis was by intention to treat with equivalence defined as amoxicillin and placebo arms were 81.7% and 84.0%, respectively (difference 2.3%, 95% CI -8.6% to 4.0%). Of 131 HIV infected

2008 EvidenceUpdates PubMed

40. Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. (Full text)

Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. Acute otitis media (AOM) is a common problem in children, for which the antibiotic amoxicillin, with or without clavulanate, is frequently prescribed.To compare the effectiveness of one or two daily doses with three or four daily doses of amoxicillin, with or without clavulanate, for the treatment of AOM in children.We searched the Cochrane Central Register of Controlled (...) differences.This review showed insufficient evidence to judge whether once or twice daily doses of amoxicillin, with or without clavulanate, were comparable with three or four daily doses for the treatment of AOM. The evidence appears to be biased and therefore no firm conclusions can be drawn.

2008 Cochrane PubMed